Elevation of the tumor marker <scp>CA19</scp>‐9 in a pancreatic cancer survivor with benign prostatic hyperplasia: A clinical case report-Reference-Cited by-同舟云学术

Elevation of the tumor marker CA19‐9 in a pancreatic cancer survivor with benign prostatic hyperplasia: A clinical case report

Published:2024-05-24 Issue:6 Volume:12 Page:
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clinical Case Reports

Author:

Pendry Steve D.¹,Singhal Nimit²,Neo Eu‐Ling³⁴,Foreman Darren⁵,Winter Jean M.¹^ORCID

Affiliation:

1. Flinders Health and Medical Research College of Medicine and Public Health Flinders University Bedford Park South Australia Australia

2. Cancer Centre, Royal Adelaide Hospital and School of Medicine The University of Adelaide Adelaide South Australia Australia

3. Hepatopancreatobiliary Surgical Unit Flinders Medical Centre Bedford Park South Australia Australia

4. Hepatobiliary Surgical Unit Royal Adelaide Hospital Adelaide South Australia Australia

5. College of Medicine and Public Health Flinders University Bedford Park South Australia Australia

Abstract

Key Clinical MessageSerum carbohydrate antigen 19‐9 (CA19‐9) is used for recurrence surveillance in patients with resected pancreatic ductal adenocarcinoma (PDAC). This report describes the association of increasing CA19‐9 in a male PDAC survivor with presence of prostatic hyperplasia. Unexplained elevation of CA19‐9 in male PDAC survivors might be attributable to benign prostatic conditions.

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.8929

Reference22 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Gastrointestinal Adenocarcinoma Incidence and Survival Trends in South Australia, 1990–2017

3. Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States

4. Surveillance Research Program NCI.SEER*Explorer: an Interactive Website for SEER Cancer Statistics.https://seer.cancer.gov/explorer2015.

5. Response to Preoperative Therapy in Localized Pancreatic Cancer

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of hyperlipidemia risk factors among pilots based on physical examination data: A study using a multilevel propensity score models;Experimental and Therapeutic Medicine;2024-06-28